Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SANA

Sana Biotechnology Inc

Jun 08 • 09:32AM ET

2.70

+0.02 0.75 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RYTM KYMR NUVL BMRN INCY VKTX KRYS AXSM MDGL NBIX

| Held by: XBI VTI IWM VXF IBB IWN VTWO SCHA VHT SMLF

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.94	Insider Own	37.57%	Shs Outstand	269.82M	Perf Week	-15.89%
Market Cap	751.39M	Forward P/E	-	EPS next Y	-0.58	Insider Trans	0.00%	Shs Float	181.10M	Perf Month	-22.86%
Enterprise Value	721.39M	PEG	-	EPS next Q	-0.15	Inst Own	54.04%	Short Float	21.24%	Perf Quarter	-18.92%
Income	-241.99M	P/S	-	EPS this Y	36.26%	Inst Trans	0.81%	Short Ratio	10.44	Perf Half Y	-47.88%
Sales	0.00M	P/B	6.11	EPS next Y	5.75%	ROA	-59.09%	Short Interest	38.47M	Perf YTD	-33.66%
Book/sh	0.44	P/C	7.13	EPS next 5Y	14.86%	ROE	-147.41%	52W High	6.55 -58.78%	Perf Year	-4.93%
Cash/sh	0.38	P/FCF	-	EPS past 3/5Y	12.33% 8.72%	ROIC	-134.67%	52W Low	2.41 12.03%	Perf 3Y	-59.70%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.43% 7.00%	Perf 5Y	-89.21%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-6.15%	Oper. Margin	-	ATR (14)	0.22	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.29	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	32.40	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	1.29	EPS Q/Q	17.99%	SMA20	-13.06%	Beta	2.19	Target Price	9.50
Payout	-	Debt/Eq	0.63	Sales Q/Q	-	SMA50	-16.41%	Rel Volume	0.94	Prev Close	2.68
Employees	142	LT Debt/Eq	0.51	Earnings	May 11 AMC	SMA200	-29.87%	Avg Volume	3.69M	Price	2.70
IPO	Feb 04, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.00% -	Trades		Volume	189,872	Change	0.75%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)